Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug

Allergy,Volume 0, Issue ja, -Not available-.

Source: Allergy - July 10, 2018 Category: Allergy & Immunology Authors: Riccardo Asero Source Type: research